Methamphetamine is a potent central nervous system stimulant that is medically available in very limited circumstances under the prescription name Methamphetamine hydrochloride (Desoxyn). It is approved in some countries, including the United States, for the treatment of attention-deficit hyperactivity disorder (ADHD) and, in rare cases, short-term management of obesity when other treatments have failed. Due to its high potential for abuse and dependence, it is classified as a Schedule II controlled substance and is prescribed with strict medical supervision.
From a clinical perspective, methamphetamine works by increasing the release and blocking the reuptake of neurotransmitters such as dopamine, norepinephr...
Methamphetamine is a potent central nervous system stimulant that is medically available in very limited circumstances under the prescription name Methamphetamine hydrochloride (Desoxyn). It is approved in some countries, including the United States, for the treatment of attention-deficit hyperactivity disorder (ADHD) and, in rare cases, short-term management of obesity when other treatments have failed. Due to its high potential for abuse and dependence, it is classified as a Schedule II controlled substance and is prescribed with strict medical supervision.
From a clinical perspective, methamphetamine works by increasing the release and blocking the reuptake of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. This leads to increased alertness, concentration, and reduced appetite. However, these effects also contribute to its high addictive potential.
In terms of dosage, when prescribed for ADHD, treatment typically begins at a very low dose, often around 5 mg once or twice daily, taken orally. The dose may be gradually increased in small increments (usually 5 mg per week) depending on the patient's response and tolerance. The total daily dose rarely exceeds 20–25 mg per day in clinical practice. For obesity, it is generally prescribed at low doses for short durations only, as part of a broader weight management program. Dosing schedules are carefully controlled to minimize the risk of dependence and adverse effects, and patients are regularly monitored.
Methamphetamine is not commonly prescribed today because safer alternatives such as methylphenidate or amphetamine-based medications are preferred. When it is used, it is typically reserved for patients who do not respond adequately to other treatments.
The side effect profile of methamphetamine is significant and can involve multiple organ systems. Common side effects include insomnia, dry mouth, loss of appetite, increased heart rate, elevated blood pressure, anxiety, and irritability. Patients may also experience restlessness, tremors, or gastrointestinal discomfort. More serious adverse effects include cardiovascular complications such as arrhythmias, hypertension, and risk of stroke or myocardial infarction, particularly in individuals with underlying heart conditions.
Psychiatric side effects are also important and may include mood swings, aggression, paranoia, hallucinations, and in severe cases, stimulant-induced psychosis. Long-term use, even at therapeutic doses, carries a risk of dependence, tolerance, and withdrawal symptoms upon discontinuation, such as fatigue, depression, and sleep disturbances.
Because of these risks, methamphetamine is contraindicated in patients with a history of substance use disorder, cardiovascular disease, uncontrolled hypertension, hyperthyroidism, or severe anxiety disorders. It should also not be used concurrently with monoamine oxidase inhibitors (MAOIs) due to the risk of hypertensive crisis.
In summary, while methamphetamine has legitimate medical uses, its prescription is rare and tightly regulated due to its high abuse potential and significant side effect profile. It is only used under careful medical supervision when the potential benefits outweigh the substantial risks.
